Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - glimepiride, quantity: 1 mg - tablet, uncoated - excipient ingredients: sodium starch glycollate; lactose monohydrate; iron oxide red; magnesium stearate; povidone; microcrystalline cellulose - dimirel is indicated as an adjunct to diet, exercise and weight loss, to lower the blood glucose in patients with non-insulin-dependent (type 2) diabetes mellitus.

Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - leflunomide -

Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - alfuzosin hydrochloride -

Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - glimepiride, quantity: 3 mg - tablet, uncoated - excipient ingredients: lactose monohydrate; magnesium stearate; iron oxide yellow; sodium starch glycollate; microcrystalline cellulose; povidone - indications: amaryl is indicated as an adjunct to diet, exercise and weight loss to lower the blood glucose in patients with non-insulin-dependent (type 2) diabetes mellitus.

Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - glimepiride, quantity: 4 mg - tablet, uncoated - excipient ingredients: magnesium stearate; microcrystalline cellulose; sodium starch glycollate; povidone; indigo carmine; lactose monohydrate - amaryl is indicated as an adjunct to diet, exercise and weight loss, to lower the blood glucose in patients with non-insulin-dependent (type 2) diabetes mellitus.

Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - glimepiride, quantity: 2 mg - tablet, uncoated - excipient ingredients: indigo carmine; sodium starch glycollate; lactose monohydrate; povidone; iron oxide yellow; magnesium stearate; microcrystalline cellulose - amaryl is indicated as an adjunct to diet, exercise and weight loss, to lower the blood glucose in patients with non-insulin-dependent (type 2) diabetes mellitus.

Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - glimepiride, quantity: 1 mg - tablet, uncoated - excipient ingredients: microcrystalline cellulose; magnesium stearate; sodium starch glycollate; lactose monohydrate; povidone; iron oxide red - amaryl is indicated as an adjunct to diet, exercise and weight loss, to lower the blood glucose in patients with non-insulin-dependent (type 2) diabetes mellitus.

Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - oxybutynin hydrochloride, quantity: 5 mg - tablet, uncoated - excipient ingredients: microcrystalline cellulose; brilliant blue fcf aluminium lake; lactose; calcium stearate - treatment of detrusor over-activity where conservative measures have failed.

Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - clomifene citrate, quantity: 50 mg - tablet, uncoated - excipient ingredients: sucrose; lactose monohydrate; maize starch; magnesium stearate; pregelatinised maize starch; iron oxide yellow - indications as at 1 january 1991: clomid is indicated for the treatment of ovarian failure in carefully selected infertile women who wish to become pregnant.

Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - nicorandil -